American International Group Interest Paid decreased by 44.6% to $67.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.9%, from $72.00M to $67.00M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows a downward trend with a -26.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $337.00M | $337.00M | $337.00M | $243.00M | $331.00M | $160.00M | $393.00M | $165.00M | $471.00M | $109.00M | $314.00M | $181.00M | $289.00M | $111.00M | $277.00M | $72.00M | $128.00M | $68.00M | $121.00M | $67.00M |
| QoQ Change | — | +0.0% | +0.0% | -27.9% | +36.2% | -51.7% | +145.6% | -58.0% | +185.5% | -76.9% | +188.1% | -42.4% | +59.7% | -61.6% | +149.5% | -74.0% | +77.8% | -46.9% | +77.9% | -44.6% |
| YoY Change | — | — | — | — | -1.8% | -52.5% | +16.6% | -32.1% | +42.3% | -31.9% | -20.1% | +9.7% | -38.6% | +1.8% | -11.8% | -60.2% | -55.7% | -38.7% | -56.3% | -6.9% |